MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
Background and purposeLocally recurrent prostate cancer after radiotherapy merits an effective salvage strategy that mitigates the risk of adverse events. We report outcomes of a cohort enrolled across two institutions investigating MRI-guided tumor-targeted salvage high dose rate brachytherapy (HDR...
Main Authors: | Cynthia Ménard, Inmaculada Navarro-Domenech, Zhihu (Amy) Liu, Lisa Joseph, Maroie Barkati, Alejandro Berlin, Guila Delouya, Daniel Taussky, Marie-Claude Beauchemin, Benedicte Nicolas, Samuel Kadoury, Alexandra Rink, Srinivas Raman, Aravindhan Sundaramurthy, Robert Weersink, Dominic Beliveau-Nadeau, Joelle Helou, Peter Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.971344/full |
Similar Items
-
Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer
by: Cynthia Ménard, et al.
Published: (2022-11-01) -
Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results
by: Olivier Lauche, et al.
Published: (2016-04-01) -
Is intraoperative real-time dosimetry in prostate seed brachytherapy predictive of biochemical outcome?
by: Daniel Taussky, et al.
Published: (2017-06-01) -
Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial
by: C. Belliveau, et al.
Published: (2022-12-01) -
Re‐salvage focal low‐dose rate brachytherapy for local recurrence of prostate cancer after salvage focal low‐dose rate brachytherapy
by: Takahiro Nakamoto, et al.
Published: (2024-01-01)